8-K - Structure Therapeutics Inc. (0001888886) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Structure Therapeutics filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
Directly affected
- GPCR Structure Therapeutics
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Structure Therapeutics belongs to, so it often moves with news about it.
- LLY Eli Lilly and+14.3% 30d
Eli Lilly and is a peer of Structure Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+3.3% 30d
Johnson & Johnson is a peer of Structure Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+9.3% 30d
AbbVie is a peer of Structure Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.4% 30d
Merck is a peer of Structure Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+6.0% 30d
Abbott Laboratories is a peer of Structure Therapeutics in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| GPCR | -4.95% | -11.05% | base | after close | after close | after close | after close |
| XLV | -2.31% | -1.80% | base | after close | after close | after close | after close |
| LLY | -0.21% | -3.19% | base | after close | after close | after close | after close |
| JNJ | -5.66% | -3.43% | base | after close | after close | after close | after close |
| ABBV | -2.53% | -1.82% | base | after close | after close | after close | after close |
| MRK | -2.73% | -1.23% | base | after close | after close | after close | after close |
| ABT | -1.01% | +2.74% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-09 AccNo: 0001104659-26-124494 Size: 333 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Structure Therapeutics (GPCR)
| Company | When | Move | Status |
|---|---|---|---|
| AbbVie (ABBV) | three days earlier | -1.82% | final price |
| AbbVie (ABBV) | five days earlier | -2.53% | final price |
| Abbott Laboratories (ABT) | three days earlier | +2.74% | final price |
| Abbott Laboratories (ABT) | five days earlier | -1.01% | final price |
| Structure Therapeutics (GPCR) | three days earlier | -11.05% | final price |
| Structure Therapeutics (GPCR) | five days earlier | -4.95% | final price |
| Johnson & Johnson (JNJ) | three days earlier | -3.43% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -5.66% | final price |
| Eli Lilly (LLY) | three days earlier | -3.19% | final price |
| Eli Lilly (LLY) | five days earlier | -0.21% | final price |
| Merck (MRK) | three days earlier | -1.23% | final price |
| Merck (MRK) | five days earlier | -2.73% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -1.80% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -2.31% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 40 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 45 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 62 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 56 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 82 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 38 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 52 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Abbott Laboratories (ABT), worth $1,001 - $15,000 on 17 Sep 2026. That is 53 days before publication. Filed 30 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Structure Therapeutics (GPCR)
Companies carried with this story
- GPCR Structure Therapeutics
In “8-K - Structure Therapeutics Inc. (0001888886) (Filer),” Structure Therapeutics (GPCR) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> GPCR
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 9 Nov 2026 story “8-K - Structure Therapeutics Inc. (0001888886) (Filer).” Reason on file: Health Care Select Sector SPDR holds the health sector that Structure Therapeutics belongs to, so it often moves with news about it
- LLY Eli Lilly
Eli Lilly (LLY) is linked, with no stored direction, medium confidence in the 9 Nov 2026 story “8-K - Structure Therapeutics Inc. (0001888886) (Filer).” Reason on file: Eli Lilly and is a peer of Structure Therapeutics in pharmaceutical preparations; rivals often move on the same news
- JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 9 Nov 2026 story “8-K - Structure Therapeutics Inc. (0001888886) (Filer).” Reason on file: Johnson & Johnson is a peer of Structure Therapeutics in pharmaceutical preparations; rivals often move on the same news
- ABBV AbbVie
In “8-K - Structure Therapeutics Inc. (0001888886) (Filer),” AbbVie (ABBV) is linked, with no stored direction, medium confidence. Reason on file: AbbVie is a peer of Structure Therapeutics in pharmaceutical preparations; rivals often move on the same news
- MRK Merck
In “8-K - Structure Therapeutics Inc. (0001888886) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck is a peer of Structure Therapeutics in pharmaceutical preparations; rivals often move on the same news
- ABT Abbott Laboratories
Abbott Laboratories (ABT) is linked, with no stored direction, medium confidence in the 9 Nov 2026 story “8-K - Structure Therapeutics Inc. (0001888886) (Filer).” Reason on file: Abbott Laboratories is a peer of Structure Therapeutics in pharmaceutical preparations; rivals often move on the same news
How “8-K - Structure Therapeutics Inc. (0001888886) (Filer)” reaches Structure Therapeutics (GPCR)
On 9 Nov 2026, “8-K - Structure Therapeutics Inc. (0001888886) (Filer)” is the story that connects Structure Therapeutics (GPCR) to this story.
Structure Therapeutics (GPCR) is on the page because SEC 8-K filing -> direct issuer disclosure -> GPCR
A second company, Select Sector Spdr Tr (XLV), is listed for a different reason: Health Care Select Sector SPDR holds the health sector that Structure Therapeutics belongs to, so it often moves with news about it
The price range for Structure Therapeutics (GPCR), and the dates in the story
LLY traded between 1158.27 and 1452.66 across 20 sessions. The latest close on file is 1354.96.
How strong the case is around Structure Therapeutics (GPCR)
46 out of 100
“8-K - Structure Therapeutics Inc. (0001888886) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.